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Background: Herpes simplex 1 (HSV-1) causes various human clinical manifestations, ranging from simple cold
sores to encephalitis. Innate immune cells recognize pathogens through Toll-like receptors (TLRs), thus initiating the
immune response. Previously, we demonstrated that the immune response against HSV-1 is dependent on TLR2
and TLR9 expression and on IFN gamma production in the trigeminal ganglia (TG) of infected mice. In this work,
we further investigated the cells, molecules, and mechanisms of HSV-1 infection control, especially those that are
TLR-dependent.
Methods: C57BL/6 wild-type (WT), TLR2−/−, TLR9−/−, and TLR2/9−/− mice were intranasally infected with HSV-1. On the
viral peak day, the TG and brains were collected from mice and TLR expression was measured in the TG and brain and
inducible nitric oxide synthase (iNOS) expression was measured in the TG by real-time PCR. Immunofluorescence assays
were performed in mice TG to detect iNOS production by F4/80+ cells. Intraperitoneal macrophages nitric oxide
(NO) production was evaluated by the Griess assay. WT, CD8−/−, RAG−/−, and iNOS−/− mice were intranasally
infected in a survival assay, and their cytokine expression was measured in the TG by real-time PCR.
Results: Infected WT mice exhibited significantly increased TLR expression, compared with their respective
controls, in the TG but not in the brain. TLR-deficient mice had moderately increased TLR expression in the TG and
brain in compare with the non-infected animals. iNOS expression in the WT infected mice TG was higher than in
the other groups with increased production by macrophages in the WT infected mice, which did not occur in the
TLR2/9−/− mice. Additionally, the intraperitoneal macrophages of the WT mice had a higher production of NO
compared with those of the TLR-deficient mice. The CD8−/−, RAG−/−, and iNOS−/− mice had 100% mortality after
the HSV-1 infection compared with 10% of the WT mice. Cytokines were overexpressed in the iNOS−/− infected
mice, while the RAG−/− mice were nearly unresponsive to the virus.
Conclusion: TLRs efficiently orchestrate the innate immune cells, eliciting macrophage response (with NO
production by the macrophages), thereby controlling the HSV-1 infection through the immune response in the
TG of mice.
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Herpesviruses are large enveloped viruses (100–200 nm)
with a double-stranded DNA genome from 120 to 230 kbp
which encodes approximately 84 proteins [1]. An estimated
70% of the world population is seropositive for human
herpes virus 1 (HHV-1), also known as herpes simplex
virus 1 (HSV-1) [1,2]. HSV-1 is the etiological agent of
orolabial and cutaneous herpes, ophthalmic lesions, kera-
titis, and kerato-conjunctivitis. Severe ophthalmic lesions,
central nervous system involvement (encephalitis), or sys-
temic infections, although rare, can occur in recently born
children or in immunosuppressed individuals [3]. Her-
pesviruses are known for their latency/recurrence phe-
nomena. HSV-1 can become latent in neuronal ganglia
(especially the trigeminal ganglia) and may reactivate
under stressful conditions, sometimes causing new dis-
ease episodes [1].
The HSV-1 infection in humans involves the intimate
contact of a susceptible individual with someone who is
shedding the virus [1]. After the primary infection,
which usually occurs in the oral mucosa, the virus repli-
cates in epithelial cells and then infects the neuronal ter-
minal, from where the virus reaches the nerve ganglia
through retrograde axonal flow. The trigeminal ganglia
harbor latent virus DNA [4,5]. Recurrences occur when
the latent virus reactivates and is transported by antero-
grade axonal flow to the primary infection site [6,7]. In
some cases, reactivated HSV-1 is transported to the cen-
tral nervous system, causing encephalitis [8]. Reactiva-
tion is normally associated with stress factors such as
hormonal alterations, ultraviolet light exposure, and im-
munosuppression [9,10]. However, a study using math-
ematical models of HSV-2 (which is closely related to
HSV-1) reactivation revealed that the virus is constantly
released from neurons in small amounts, thereby activat-
ing the immune system, which in turn inhibits viral repli-
cation and promotes a balance that prevents the clinical
reactivation of the disease [11].
Immune responses against HSV-1 involve both innate
and acquired immunity. Innate responses are largely me-
diated by leukocytes such as neutrophils, macrophages,
and dendritic cells, which phagocytose pathogens and co-
ordinate additional responses with the synthesis of a var-
iety of inflammatory mediators and cytokines. Toll-like
receptors (TLRs) are proteins that confer ‘specificity’ to
the innate immune system, allowing the recognition of
pathogen associated molecular patterns (PAMPs) [12,13].
The mRNAs from all TLR types (except TLR3) are ex-
pressed by monocytes and macrophages [13]; in the
central nervous system (CNS), while microglia express
mRNA from TLR1 to TLR9, neurons and oligodendro-
cytes express only TLR3 [12]. During the last decade, the
important roles of innate immunity responses and TLRs
in HSV-1 infection control have been highlighted [14-19].HSV-1 infection control appears to be highly dependent
on the cellular immune response, including local tissue
cells such as microglia and resident macrophages, as well
as inflammatory infiltration by cells such as monocytes
and CD8+ T lymphocytes [19-23]. This control most likely
occurs through the production of cytokines such as IFN
gamma, especially in the trigeminal ganglia [19,24,25].
IFN gamma is produced mainly by T lymphocytes [26],
and one of its major actions is to increase iNOS and
ROS production for killing pathogens [26,27]. iNOS,
IFN gamma, and other pro-inflammatory cytokines are
important for controlling the HSV-1 infection in the tri-
geminal ganglia through the action of macrophages and
CD8+ T cells [19,28], although this effect in the brain is
controversial [19,28,29].
Data from our group, which uses the murine intrana-
sal infection model, have indicated that the crucial ‘spot’
for immune defense organization against HSV-1 most
likely is the trigeminal ganglia and not the brain
[14,19,28,30,31]. Most C57BL/6 wild-type (WT) mice
infected with 106 p.f.u. of HSV-1 can control the infec-
tion and survive [19,31]. These studies have also dem-
onstrated that certain chemokines and IFN gamma
expression in trigeminal ganglia exhibit the same tem-
poral profile of viral replication, with peaks of expres-
sion occurring at day 5 post infection (which most likely
facilitates controlling the virus), while mice without
signs of encephalitis do not harbor the virus in their
brains [19]. Apparently this control is not as efficient in
mice with deficiencies in their immune response be-
cause knockout mice for MyD88, IFN gamma [15],
TLR9, and TLR2/9 [19] have high mortality rates and
die with signs of encephalitis after HSV-1 infection.
Additionally, the virus is found in the brains of these
animals.
The high prevalence of HSV-1 and the considerably in-
creased number of immunosuppressed individuals due to
diseases or to therapeutic transplantation, heighten the im-
portance of comprehending the mechanisms of immune
defense against the virus in a herpetic encephalitis model.
In the present work, we demonstrate that macrophage-
mediated immunity against HSV-1 occurs efficiently through
iNOS in trigeminal ganglia and appears to be organized by
the initial activation of TLR2 and TLR9 (with a possible
interrelation of these receptors with other TLRs), which con-
tributes to viral infection control.Materials and methods
Virus
HSV-1 strain EK [32], which was isolated from a human
case of recurrent oral herpes with blisters, was multiplied
in Vero cells [15] and purified [33] as previously described.
The virus titers obtained were 3.0 × 109 p.f.u./mL.
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Vero cells (ATCC) were maintained in MEM supple-
mented with 5% heat-inactivated FBS and antibiotics in
5% CO2 at 37°C. These cells were used for multiplication
and titration of the virus.
Mice
TLR2−/− and TLR9−/− mice were generated at Osaka
University (Osaka, Japan), and the TLR2/9−/− mice were
obtained by crossing the TLR2−/− and TLR9−/− mice at
the NIH (USA) and by backcrossing them to the C57BL/6
background for eight generations. These mice were a kind
gift of Shizuo Akira and Alan Sher, respectively. C57BL/6
RAG−/−, C57BL/6 iNOS−/−, and C57BL/6 CD8−/− mice
were acquired from Biotério Fiocruz/Rio. The C57BL/6
(WT, control) and knockout mice were maintained in a
pathogen-free, barrier environment in Centro de Pesquisas
René Rachou, Oswaldo Cruz Foundation (CPqRR/FIO-
CRUZ) (Belo Horizonte, Minas Gerais, Brazil). Six- to
10-week-old male mice were anesthetized with keta-
mine (Agribrands do Brasil Ltda, Brazil), and 106 p.f.u.
of the purified HSV-1 contained in 10 μL was inhaled by
the mice as described previously [34]. The control mice
inhaled PBS. The mouse colonies and all of the experi-
mental procedures were performed according to the in-
stitutional animal care and use guidelines from CPqRR/
FIOCRUZ. The project was previously approved by the
Ethics Committee in Animal Experimentation (CEUA
from CPqRR/FIOCRUZ LW6/11).
 Intraperitoneal macrophages
Thioglycollate-elicited peritoneal macrophages were
obtained from either C57BL/6, TLR2−/−, TLR9−/−, or
TLR2/9−/− mice by peritoneal washing, were activated
with sub-optimal concentration of murine IFN gamma
(50 U/mL) as previously described [15] and then were
stimulated with HSV-1 (MOI of 10) for 24 h. The Griess
reaction assay [35] was performed to evaluate nitric
oxide production in the supernatants.
Griess reaction assay
Thioglycollate-elicited peritoneal macrophages were ob-
tained from either C57BL/6, TLR2−/−, TLR9−/−, or
TLR2/9−/− mice by peritoneal washing. Adherent peri-
toneal macrophages were cultured in 96-well plates (2 ×
105 cells/well) at 37°C/5% CO2 in Dulbecco’s modified
Eagle’s medium (Life Technologies, Paisley, UK) supple-
mented with 5% heat-inactivated fetal bovine serum
(Life Technologies), 2 mmol/L L-glutamine (Sigma) and
40 μg/mL of gentamicin (Schering do Brasil, Rio de Janeiro,
Brazil). Next, the cells were stimulated with HSV-1 (multi-
plicity of infection, 10), for 24 h to evaluate nitric oxide
production in the supernatants.RNA extraction
Trigeminal ganglia and brains were aseptically removed and
stored at −70°C until processing. RNA extraction was per-
formed according to the procedures provided by the manu-
facturer of TRIzol reagent (Invitrogen, USA). The RNAs
were treated with DNase (Biolabs, USA). One microliter of
the extracted RNA was quantified in a Nanodrop ND-1000
spectrophotometer, at wavelengths of 260 and 280 nm.
Reverse transcription
Reverse transcription was performed according to the
procedures provided by the manufacturer of the M-MLV
RT enzyme (Promega, USA).
Real-time PCR
Real-time quantitative PCR (Applied Biosystems, USA)
was performed to verify the mRNA expression in the tri-
geminal ganglia and brain of mice infected with HSV-1.
The reactions were performed using the Sybr Green
PCR Master Mix (Applied Biosystems, USA) in the Ap-
plied Biosystems’ 7000 Sequence Detection System, at
50°C, 2’; 95°C, 10’; and 40 cycles of 95°C, 15” and 60°C, 1’,
followed by a final dissociation stage. The oligonucleotides
used in the reactions were specific for HPRT, F - GTT
GGA TAC AGG CCA GAC TTT GTT G and R - GAT
TCA ACT TGC GCT CAT CTTAGG C; IP-10 (CXCL10),
F -GCC GTC ATT TTC TGC CTC AT and R - GCT
TCC CTA TGG CCC TCA TT; TNF alpha, F - CAT CTT
CTC AAA ATT CGA GTG ACA A and R - TGG GAG
TAG ACA AGG TAC AAC CC; iNOS, F - CAG CTG
GGC TGTACA AAC CTTand R - CAT TGG AAG TGA
AGC GTT TCG; MCP-1(CCL2), F - CTT CTG GGC
CTG CTG TTC A and R - CCA GCC TAC TCA TTG
GGA TCA [36]; RANTES (CCL5), F - GTC GTG TTT
GTC ACT CGA AGG A and R - GAT GTA TTC TTG
AAC CCA CTT CTT CTC; gp91, F - CCA ACT GGG
ATA ACG AGT TCA AGA C and R - AAG GCT TCA
GGG CCA CAC A; p22, F - TGG CTA CTG CTG GAC
GTT TCA C and R - CTC CAG CAG ACA GAT GAG
CAC AC; VP16 F - TTT GAC CCG CGA GAT CCT AT
and R - GCT CCG TTG ACG AAC ATG AA [37]; TLR1,
F - TGA TCT TGT GCC ACC CAA CA and R - GCA
GGG CAT CAA AGG CAT TA; TLR2, F - TTG CTC
CTG CGA ACT CCT AT and R - AGC CTG GTG ACA
TTC CAA GA; TLR3, F - TAG ACT GCA TCG CCT
GCT AA and R - AAG CAG CCA GAA GCA GAA CT;
TLR6, F - TCT GGG ATA GCC TCT GCA ACA and R -
GGC GCA AAC AAA GTG GAA AC; TLR7, F - TAC
CAG GAC AGC CAG TTC TA and R - AGG AGC CTC
TGA TGA GAC AA; and TLR9, F - ACC TCA GCC ACA
ACA TTC TC and R - TGC ACC TCC AAC AGT AAG
TC [38]. The comparative Ct method was chosen to
analyze the data, using the arithmetic formula 2-ΔΔCt [39].
The genes expression was normalized to expression of
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phosphoribosyltransferase (HPRT). All of the reactions
were replicated.
Histopathology
Samples were fixed with 10% formaldehyde in phosphate
buffer, routinely processed and embedded in paraffin, as


















































































































































































Figure 1 TLR expression in the mouse trigeminal ganglia. Mice were e
and they were euthanized 5 days thereafter. The trigeminal ganglia were c
real-time PCR for TLR expression indices for C57BL/6 or the indicated knock
obtained (*P <0.05; **P <0.01; ***P <0.001 when comparing the infected an
###P <0.001, when comparing the infected C57BL/6 mice with the infected
that yielded similar results.Histopathology and immunostaining
For trigeminal ganglia immunostaining, samples were
frozen in the Tissue-Tek O.C.T. compound (Sakura,
Netherlands), and 5 μm slices were cut using a HM505N
microtome cryostat (Microm, USA). The tissues were
stained as previously described [40], with modifications.
Immediately thereafter, primary antibodies were incubated















































































































































ither infected intranasally with 106 p.f.u. of HSV-1 or were not infected,
ollected, and the RNA was extracted, reverse transcribed in cDNA and
out (NI) (n = 4) or the respective infected groups (n = 6 to 9) were
imals with the respective non-infected animals); (#P <0.05, ##P <0.01,
knockout mice). The results are representative of two experiments
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Hoechst (0.2 μg/mL) (Molecular Probes, USA) and
mounted in the Hydromount aqueous medium (National
Diagnostics, USA). The primary antibody used was rat
anti-F4/80, 1:50 (Serotec MCAP497, USA) or rabbit anti-
iNOS, 1:5,000 (Spring Bioscience E3740, USA).
The secondary antibody was Alexa Fluor 488 goat
anti-rat IgG (1:500) (Molecular Probes, USA) or goat
anti-rabbit IgG (1:500) (Molecular Probes, USA). The
Immunostains were observed and photographed via an
Olympus BX51 microscope (Olympus, Japan) using a




















































































































































































Figure 2 TLRs expression in mice brains. Mice were either infected intra
euthanized 5 days thereafter. The brains were collected, and the RNA was ext
indices for C57BL/6 or the indicated knockout (NI) (n = 4) or the respective inf
comparing the infected animals with the respective non-infected animals); (#P
infected knockout mice). The results shown are representative of two experimMorphometry
We quantified at least three fields per sample (n = 3/
group). Each field generated three superimposed images
obtained under a microscope Olympus BX51 (Olympus,
Tokyo, Japan), using three fluorescence filters (iNOS,
F4/80, Hoechst). The images were transferred by video
camera Cool SNAP-colored Procf Color (Media Cybernetics,
Bethesda, MD, USA) to a computer system coupled to
video using the Image program-Pro Express version 4.0
for windows (Media Cybernetics, Bethesda, MD, USA).
Quantification of total cells (Hoechst) and iNOS positive
cells and F4/80 markers was performed with the aid of the














































































































































nasally with 106 p.f.u. of HSV-1 or not infected and they were
racted, reverse transcribed in cDNA and real-time PCR for TLR expression
ected groups (n = 6 to 9) were obtained (*P <0.05; **P <0.01, when
<0.05; ##P <0.01, when comparing the infected C57BL/6 mice with the
ents that yielded similar results.
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The analyses were performed using the GraphPad Prism
5 software for Windows (GraphPad Software, Inc., La
Jolla, CA, USA). The sample groups were assessed by
non-parametric or parametric tests, according to the
Kolmogorov-Smirnov normality. Real-time PCR results
were statistically analyzed using Mann–Whitney non-
parametric T-tests. Macrophage results were analyzed by
unpaired T-tests. For the survival curves, the statistical
































































































































Figure 3 iNOS, gp91, and p22 expression in the trigeminal ganglia of
macrophages. Mice were infected intranasally with 106 p.f.u. of HSV-1 and
were collected, the RNA extracted, reverse transcribed in cDNA and real-tim
gene were performed. (D) Macrophages derived from the C57BL/6 mice or
wells/group) (black bars) or were non-infected (NI, white bars), and the lev
stimulation, by the Griess reaction assay. The bars represent the S.E.M. (*P <
non-infected macrophages; #P <0.05 or ##P <0.01 when comparing the C5
This experiment is representative of two analyses.Results and discussion
Expression of TLRs in HSV-1 infected mice TG and brains
occurs in a TLR-interdependent manner
Inter-relationships between the TLR gene expression
levels were already evidenced by previous research in
which mice pre-stimulated with a TLR3 agonist, poli
I:C, exhibit increased TLR2 expression in the brains and
reduced mortality after the HSV-1 infection [41]. Al-
though the importance of TLR2 and TLR9 in the HSV-1






















































































































the infected mice and NO production in the infected peritoneal
were euthanized 5 days after the infection. The trigeminal ganglia
e PCR for the expression of (A) gp91phox, (B) p22phox, and (C) iNOS
the indicated knockout mice were infected with HSV-1 (MOI of 10, five
els of nitric oxide (NO) were determined in the supernatants, 24 h after
0.05, when comparing the infected macrophages to the respective
7BL/6 infected macrophages with the knockout infected macrophages.
Figure 4 NO production by F4/80+ cells in the trigeminal ganglia of the infected mice. C57BL/6 (A, B, C, D) or TLR2/9−/− (E, F, G, H) mice
were either inoculated with 106 p.f.u. of HSV-1 or with PBS (uninfected) via the intranasal route; on the fifth d.p.i., the trigeminal ganglia were
collected and processed for analysis. (A) anti-iNOS Ab (green), C57BL/6 uninfected (400×); (B) anti-iNOS Ab (green), C57BL/6 infected (400×);
(C) anti-iNOS Ab (red) plus anti-F4/80 Ab (green), C57BL/6 uninfected (100×); (D) anti-iNOS Ab (red) plus anti-F4/80 Ab (green), C57BL/6 infected,
(200×); (E) anti-iNOS Ab (green), TLR2/9−/− uninfected, (100×); (F) anti-iNOS Ab (green), TLR2/9−/− infected (400×); (G) anti-iNOS Ab (red) plus
anti-F4/80 Ab (green), TLR2/9−/− uninfected (400×); (H) anti-iNOS Ab (red) plus anti-F4/80 Ab (green), TLR2/9−/− infected (400×). All of the nuclei
were stained with Hoechst (blue). Thin arrows (B, insert in B, F, insert in F) indicate stained iNOS cells (green); block arrows (D) indicate staining
only for F4/80 (green) and thin arrows (D) indicate double staining for F4/80 and iNOS (brown). Short arrows (H) indicate staining for F4/80 (green),
and long thin arrows (H) indicate stained nuclei (blue) characteristic of polymorphonuclear leukocytes.
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plored. To investigate this inter-relationship, we ana-
lyzed the expression of several TLRs in trigeminal
ganglia (TG) and brains of WT and knockout mice for
TLR2, TLR9, and TLR2/9, after infection with HSV-1,
to determine whether the deaths of TLR2/9−/− mice [19]
after HSV-1 infection occur exclusively because of the
absence of these specific TLRs or whether their absence
could interfere with the expression and/or recognition
through other TLRs.
WT, TLR2−/−, TLR9−/−, and TLR2/9−/− mice were intra-
nasally infected with 106 p.f.u. of HSV-1 [19] and were eu-
thanized on the fifth day post infection (day of the TG
viral peak) [19], and the TG and brains were collected to
evaluate the TLR expression by real-time PCR.
Data of the TLR expression in the WT infected mice re-
vealed that TLRs are highly expressed in the TG (Figure 1),
but there was no increase in TLR expression in the brain
(Figure 2), thereby demonstrating that the innate immun-
ity against HSV-1 in this model occurs preferentially in
the TG. In vitro assays from another research group [42]
have revealed the synergic action of IFN gamma and IFN
alpha/beta in controlling HSV-1 infection. These cyto-
kines genes are activated by phosphorylation cascades
that, in turn, are initiated by different TLRs, and this syn-
ergistic action impairs viral replication.
The remaining results of this assay (Figures 1 and 2) in-
dicate that TLRs 1, 2, 3, 6, 7, and 9 are expressed in the
TG of WT mice infected with HSV-1. Expression of TLR1,
TLR2 (except for the TLR2−/− and TLR2/9−/− mice), TLR3,
TLR6, TLR7, and TLR9 (except for the TLR9−/− and TLR2/
9−/− mice) in the TG (Figure 1), was generally dimin-
ished in TLR knockout mice compared with WT mice.
These results suggest an interaction of different TLRs
for immune-response orchestration in the TG of WT
mice. In the knockout mouse brains (Figure 2), there
was an increase or a tendency toward an increase inFigure 5 Survival rates of the CD8−/−, RAG−/−, and iNOS−/− mice after
(n = 10 for each group), and the mouse mortality was measured daily. C57B
The statistical analyses were performed using the log-rank test. ***P <0.001
mice. This experiment is representative of two analyses.TLR1 (except for the TLR2/9−/− mice), TLR2 (except for
the TLR2−/− and TLR2/9−/− mice), TLR3, TLR6 (except
for the TLR2/9−/− mice), TLR7, and TLR9 (except for
the TLR9−/− and TLR2/9−/− mice) expression. These results
suggest an interaction of different TLRs for immune-
response orchestration in the brains after a deficient
response in the TG.
When HSV-1 recognition by TLRs in the TG failed (in
the case of certain TLR-knockout mice), there was a weak
immune response in the brains. In TLR2−/− infected mice
(which have a mortality rate of 10% [19], similar to WT)
this brain response appears efficiently control the virus,
thereby reinforcing the fundamental role of TLR9 (which
is expressed in these animal brains). By contrast, mice that
do not express TLR9 (that is, TLR9−/− and TLR2/9−/−
mice) cannot control the virus and die, although they ex-
press other TLRs in their brains. Double knockout mice
(TLR2/9−/−) not only had diminished expression of TLR
in their TG but also did not express TLR1 and TLR6 in
their brains, most likely caused by difficulty of the im-
mune system in orchestrating a compensatory defense
without the functional presence of TLR2 and TLR9, which
is in accordance with the mortality rate of 100% in the
TLR2/9−/− group [19].
Another relevant piece of data is the significant rise in
the IFN gamma and IL-1 beta expression in the brain of
TLR2−/− compared with their non-infected controls [19].
These cytokines are crucial for an efficient immune re-
sponse in the TG of WT infected mice [19]. Although the
TLR2−/− mice had a mortality rate similar to WT mice
when infected by HSV-1, the former had lower levels of
TLR1 and TLR7 expression in the TG but higher levels of
TLR1, TLR3, TLR6, TLR7, and TLR9 expression in the
brain. Taken together, these results corroborate the hy-
pothesis that TLR2−/− mice are capable of mounting a
compensatory immune response in the brain, despite the
deficient response in the TG.the HSV-1 infection. Mice were inoculated with 106 p.f.u. of HSV-1
L/6 (circle), CD8−/− (square), iNOS−/− (diamonds), and RAG−/− (triangle).











































































































































































































































































































Figure 6 (See legend on next page.)
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Figure 6 Virus transcript, inos and cytokine expression in the trigeminal ganglia of the RAG−/− and iNOS−/− mice. The C57BL/6, RAG−/−,
and iNOS−/− mice were inoculated either with 106 p.f.u. of HSV-1 or with PBS (uninfected) by the intranasal route; on the fifth d.p.i., the trigeminal
ganglia were collected and processed for analysis to verify the expression of the viral gene VP-16 and the inos, tnf alpha, mcp-1, rantes, and ip-10
genes. *P <0.05; P <0.01, when comparing the infected mice with the respective non-infected mice. #P <0.05; ##P <0.01, when comparing the
C57BL/6 infected mice with the indicated infected knockout mice. The displayed results are representative of two experiments that yielded
similar findings.
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TLR-dependent during HSV-1 infection
Our previous experiments indicated the importance of
macrophages, CD8+ T lymphocytes and IFN gamma [19]
for HSV-1 infection control in the murine model of intra-
nasal infection. IFN gamma production by CD8+ T lym-
phocytes could be fundamental to macrophage activation
in trigeminal ganglia in these conditions, increasing the re-
active oxygen species (ROS) and reactive nitrogen species
(RNS) production by this type of cell [26]. Subsequently, we
investigated which mechanisms of monocytes/macrophages
responses are involved in HSV-1 control.
To this end, the TG of WT and knockout mice were
collected 5 days after intranasal infection, and the iNOS,
gp91, and p22 expression was evaluated by real-time
PCR. iNOS is the enzyme responsible for NO produc-
tion and, consequently, RNS [27]. gp91 phox and p22 phox
are NADPH oxidase subunits that are membrane-bound
protein components of flavocytochrome b558, which is
responsible for electron transport [43,44] and ROS
production.
The infected-mouse groups displayed a significant in-
crease in gp91phox and p22phox compared with the respect-
ive non-infected controls (Figure 3A and B, respectively).
Furthermore although the WT infected mice expressed
these genes with a tendency toward higher levels than in
the knockout mice, the difference between them was not
statistically significant. iNOS expression was increased in
WT and knockout infected compared with non-infected
mice, with a more pronounced expression in the WT mice
than in the other groups (Figure 3C). iNOS effectively
contributes to the HSV-1 defense, and our results indicate
that TLRs are important for iNOS activation/production,
while ROS apparently do not play a relevant role in this
model’s TLR-dependent response.
To confirm the TLR importance for NO production,
peritoneal macrophages of WT, TLR2−/−, TLR9−/−, and
TLR2/9−/− mice were stimulated with HSV-1 (MOI = 10),
and the NO production was evaluated by the Griess reac-
tion (Figure 3D). The WT infected-mouse group pre-
sented higher amounts of NO compared with the controls
and the knockout-infected mouse groups. This result cor-
roborates publications that indicate the importance of
iNOS in the defense against HSV-1 and the ability of NO
to inhibit HSV-1 replication in vitro [21,45,46]. Moreover,this finding confirms the importance of TLR2 and TLR9
in NO production.
Additionally, immunofluorescence assays were per-
formed to visualize iNOS production by F4/80+ cells in
the TG. In the single-staining assays, TG slices were in-
cubated with antibodies against iNOS stained with Alexa
Fluor 488 (green) and were counterstained with Hoechst
(blue) for nuclei visualization (Figures 4A, B, E, F). In
the double-staining assays, TG slices were incubated
with antibodies against F4/80 stained with Alexa Fluor
488 (green) and antibodies against iNOS stained with
Alexa Fluor 546 (red), and then counterstained with
Hoechst (Figures 4C, D, G, H). The panels in (Figure 4)
display the details of the ganglia cell immunofluoresce.
There was no iNOS production in the single-stained cells
of the non-infected mouse TG (Figure 4A and E - green) or
in the double-stained cells (Figures 4C and G - red). The
WT infected mice (Figure 4B) had thin cytoplasmic prolon-
gations stained in green (insert). Most of the WT mouse
cells (blue nuclei) expressed the enzyme (Figure 4B), and
there was a considerable superposition of F4/80 and
iNOS in the double-stained cells (green + red = brown)
(Figure 4D), indicating that monocytic cells are the
main producers of iNOS in the TG. Some F4/80 positive
cells did not express iNOS (thick arrows, Figure 4D);
however, many cells were double stained (insert, arrow).
In the TLR2/9−/− infected mice, the iNOS cell staining
was modest (Figure 4F - long arrows). Although the in-
flammatory infiltration was conspicuous (Additional file 1:
Figure S1 and Additional file 2: Commentary on the results
and discussion in Additional file 1: Figure S1), the cells
were predominantly polymorphonucleated, with segmented
nuclei, and a few macrophages were stained with F4/80
(Figure 4H - long arrows). Few mononuclear F4/80 positive
cells were visible in the TG slices from the TLR2/9−/− mice
(Figure 4H - insert, arrows), and iNOS-stained cells were
rare (Figure 4H - selection).
Altogether, the TG immunofluorescence revealed a
greater iNOS production by F4/80 positive cells in the
WT infected mice (Figure 4B and D), in comparison to
TLR2/9−/− (Figure 4F and H), which have a high mortality
rate when infected by HSV-1 [19]. The morphometry
(Additional file 3: Figure S2 and Additional file 2: Com-
mentary on the results and discussion in Additional file 3:
Figure S2) did not show statistically significant difference
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nor in the production of iNOS by macrophages between
infected C57BL/6 and infected TLR2/9−/− mice. However,
there was a clear trend towards higher levels of iNOS, more
macrophages, and more iNOS producer macrophages in
infected C57BL/6 mice than in infected TLR2/9−/− mice.
We therefore believe that this trend is biologically relevant.
Macrophages and lymphocytes are essential for
controlling HSV-1 infection
To confirm the importance of lymphocytes and macro-
phages against the HSV-1 infection in the experimental
model of herpetic encephalitis, RAG−/−, iNOS−/−, CD8−/−,
and WT mice (n = 10 from each group) were intranasally
infected with 106 p.f.u. of HSV-1 [19] to evaluate the mor-
tality (Figure 5), and the control mice aspirated only PBS.
The animals were checked daily for encephalitis signs such
as prostration, ruffled fur, limb paralysis, and hunched pos-
ture, and mice showing these signs were euthanized.
All of the control mice survived, and the WT mice ex-
hibited 90% survival (Figure 5); no CD8−/−, RAG−/−, or
iNOS−/− mice survived (Figure 5). These results indicate
that not only T and B lymphocytes [15,19] but also iNOS
production is essential to control the viral infection, in ac-
cordance with the results reported by other researchers
[21] who have demonstrated the importance of NO for
preventing HSV-1 replication in the TG.
Additionally, the WT, RAG−/− and iNOS−/− mice’s
cytokine and viral transcript expression was evaluated in
the TG by real-time PCR, 5 days after the infection. The
viral transcripts were similarly expressed in all of the in-
fected mice, but the RAG−/− mice were nearly irrespon-
sive to the virus in terms of their chemokines, effector
cytokine (TNF alpha) and iNOS expression (Figure 6).
The chemokines MCP-1, Rantes, and IP-10, which at-
tracts immune cells to the infection site, as well as the
effector cytokine TNF alpha, were over-expressed in the
iNOS−/− infected mice compared with the WT mice. Be-
cause all of the infected iNOS−/− mice died (Figure 5),
we can assume that, although murine cells can use che-
mokines to recruit immune cells to the infection site,
these immune cells fail to combat the virus because they
are not able to produce nitric oxide. In the most likely
compensatory mechanism, the cells produce more che-
mokines to attract additional immune cells, which pro-
duce more TNF alpha; however, this process is not
sufficient to control the HSV-1 infection.
In summary, we conclude that, subsequent to infection
by HSV-1, TLRs efficiently organize the innate immune
cells, thereby eliciting a CD8+ T cell [19] and macrophage
response (with NO production by the macrophages) to
control the HSV-1 infection in the mouse TG, thereby
preventing severe disease outcomes, such as encephalitis
and death.Additional files
Additional file 1: Figure S1. The animals were intranasally inoculated
with 106 p.f.u. of HSV-1 or PBS (control). On the fifth d.p.i., the trigeminal
ganglia were collected, and representative sections were processed for
histological analysis (H&E stained sections). Uninfected (A) and infected
C57BL/6 mice (B); uninfected (C) and infected TLR2−/− mice (D); uninfected
(E) and infected TLR9−/− mice (F); uninfected (G) and infected TLR2/9−/− mice
(H). The architecture and cellularity appeared normal in the uninfected
groups. All of the infected animals displayed inflammatory characteristics,
with increased cellularity and histologically evident vascular phenomena
(edema) and inflammatory changes. The higher intensity of diffuse
infiltration by polymorphonuclear cells was accompanied by degenerative
neuronal phenomena in the TLR9−/− (F) and TLR2/9−/− (H) mouse groups,
compared with the other groups of mice. The lower intensity of inflammation
occurred in the C57BL/6 mouse group (B). Original magnifications, 100×;
inserts 400 × .
Additional file 2: Supplementary Material. Supplementary statistics
data from Figures 1 and 2. Commentary on the results and discussion in
Additional files 1 and 3: Figure S1 and S2.
Additional file 3: Figure S2. Morphometry. For quantification of the
immunostained cells, C57BL/6 (n = 5) or TLR2/9−/− (n = 5) mice were
infected and after 5 days they were euthanized, the trigeminal ganglia
were collected and processed for analysis and graphic comparison of the
fluorescence, as stated in materials and methods. (A) anti-iNOS Ab; (B)
anti-F4/80 Ab; (C) anti-iNOS plus anti-F4/80 Abs.Competing interests
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